Bluefish Pharmaceuticals, Medivir deal

Medivir's BioPhausia AB subsidiary sold its BMM Pharma AB generics subsidiary to generics company Bluefish for SEK38 million ($6 million) in cash. BioPhausia said the deal will allow it to focus on t...